 |
|
Prostate Cancer Trial Results
1. Zoledronic Acid Reduces Bone Complications of Advanced Prostate Cancer
(Posted: 06/21/2002, Updated: 06/14/2004) - In a study published in the October 2, 2002, issue of the Journal of the National Cancer Institute, patients with prostate cancer that had spread to the bones had fewer fractures and other bone complications when they took a new drug, zoledronic acid (also called zolendronate or Zometa®) than when they took a placebo.
2. First Evidence That Chemotherapy Extends Life in Advanced Prostate Cancer
(Posted: 06/07/2004) - Chemotherapy regimens that include the drug docetaxel extend median survival by two to three months in patients with advanced prostate cancer that is no longer responsive to hormone therapy, two large phase III studies have shown. These are the first clinical trials to show that chemotherapy can improve survival in advanced prostate cancer.
3. Some Men with Low PSAs Have Prostate Cancer
(Posted: 05/26/2004) - Men with low PSA (prostate specific antigen) levels on screening tests can still have prostate cancer, according to a study released today by scientists from the National Cancer Institute (NCI), part of the National Institutes of Health, and the Southwest Oncology Group, an NCI-funded network of researchers.
4. Pamidronate Fails to Relieve Bone Complications of Prostate Cancer
(Posted: 01/29/2004) - In a combined analysis of two randomized trials, the drug pamidronate (brand name, Aredia®) failed to relieve bone pain or prevent fractures in men with advanced prostate cancer that had spread to the bones.
5. Surgery Helps Relieve Spinal Cord Compression Caused by Metastatic Cancer
(Posted: 06/02/2003) - Surgery followed by radiation is more effective than radiation alone in treating spinal cord compression caused by metastatic cancer.
1 2 Next >
|
|
|
